Vatsala Naageshwaran, M.S., Ph.D’s Post

Bluestar BioAdvisors' podcast Biotech Matters episode 4 just dropped. My colleagues #Erin Olsen and #Jeff Fineberg dissect the latest ADC landscape and give a fair and balanced view of this hot space, in a detailed and expertise- based fashion. Download #Biotech Matters and let us know your thoughts. https://lnkd.in/gx_ciRGH

Chief Medical Officers from biotech companies Xalud Therapeutics, Inc., SparingVision, Altimmune, Inc.and Zai Lab joined us at the CMO Summit 360º in April to explain how they pitch to different investors and how their pitching methodology has evolved over time. Learn more valuable insights and lessons through this podcast. Listen to the podcast here: https://lnkd.in/gPNs6FmM #CMO #CMO360

In the latest episode of Healio’s Oncology Overdrive podcast, our Co-founder and Chief Scientific Officer, Brian Fiske, Ph.D., joined Shikha Jain, MD, FACP to discuss entrepreneurship in #biotech, #ADC developments and more. Tune in to learn how his career through biotech has helped shape his current role at Mythic as we strive to develop better ADCs for patients everywhere.    Listen here: https://bit.ly/4eqUvEs    Healio | HemOnc Today  

🎧 Did you catch this episode of Molecule to Market: From banking to biotech In this episode, Raman Sehgal is joined by Audrey Greenberg, Co-founder of the Center for Breakthrough Medicines - now part of SK pharmteco Together, they discuss: 👉 How a career in real estate financial services led her to the world of CGT 👉 The story of the creation of the Center for Breakthrough Medicines to its eventual sale and 'fit' with SK Pharmteco 👉Why Philadelphia's "Cellicon Valley" is becoming one of the hottest life science clusters in the US Listen below, you don't want to miss it! #PharmaPodcast #CDMO #Podcast

Great listen! 🎙️ Exciting News! 🎙️ A new episode of the #BirthOfABiotech podcast is now available, featuring Gary O'Neill, Chief Scientific Officer of the company. 🌟 In this episode, Gary unveils their next-generation chemoproteomics platform, aiming to open up the entire proteome to small molecule screening for the first time, potentially making undruggable proteins druggable. 💊 Listeners will hear Gary and the company's CEO, Jeff Jonker, discuss Belharra's multi-year partnership with Genentech and their collaborative approach to working as a unified team. 🤝 The episode delves into the immense positive impact the company's science and platform could have for individuals and society, as they strive to create medicines for currently intractable diseases. 🌍 Tune in now to listen to the full episode! 🔊👂 #Podcast #Biotech #Chemoproteomics #CompanyFormation #CompanyBuilding #Partnership 💡

Steven Yatomi-Clarke from Prescient Therapeutics recently caught up with Chris Titley from Sub11 in a great podcast. Chris and Steven Yatomi-Clarke chat around Prescient Therapeutics. Steven delves in to the history of the business , the growth of the portfolio and the importance of PTX-100 to the business. Steven talks about the importance of PTX-100 , the process of design, the testing, how it works and also how meaningful the future results are. Steven also talks about the timeline of broader advances in medicine, the time, the effort as well as trends in AI. Listen here: https://lnkd.in/envQgg55 #Sub11 #Podcast #PrescientTherapeutics #PrecisionMedicine #CancerResearch #Oncology #Biotechnology #HealthcareInnovation #FutureOfMedicine

Back in the 2nd episode of “The Conversational Flow” #podcast, Brian Wile, PhD and Adam C. felt that the best topic to discuss was that of #SampleCollection, #SampleProcessing, and the important role it plays in #FlowCytometryAnalysis. This is an often discussed topic – What is the best way to collect and process samples – and it really comes down how you plan to use the samples. When looking at certain assays, fresh samples are needed, whereas with others, frozen samples may not only be acceptable – they may even be preferable. Brian and Adam dive into this episode with all the info you will need to make your sample decisions in the future! https://lnkd.in/ghwZBWwh

Adiso is keeping #patientsfirst by working to shape a brighter future free from the burden of inflammatory disease. Listen to our recent conversation with Rahul Chaturvedi of the Biotech2050 podcast. https://t.ly/lF_JG #Leadership #IBD #ulcerativecolitis

There are several ways in which you can do LC–MS/MS, including a bottom-up approach, a middle-down or top-down analyses. Learn about the methods you can use to do this kind of analysis and when they’re appropriate in latest our podcast episode in collaboration with QPS Holdings, LLC. Check it out! >>> https://hubs.ly/Q02qJ6Vg0

Holly May with another knowledge drop! This time with a podcast about the importance of building strong teams and investing in the growth of your people. Give the episode a listen here: https://lnkd.in/gAnFvJq8